Reprint of: Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere.

Journal

Nephrologie & therapeutique
ISSN: 1872-9177
Titre abrégé: Nephrol Ther
Pays: France
ID NLM: 101248950

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 04 10 2020
revised: 30 10 2020
accepted: 02 11 2020
pubmed: 21 3 2021
medline: 29 10 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

Living with chronic kidney disease (CKD) is associated with hardships for patients and their care partners. Empowering patients and their care partners, including family members and friends involved in their care, may help minimize the burden and consequences of CKD-related symptoms to enable increased life participation. There is a need to broaden the focus on living well with kidney disease and reengagement in life, including emphasis on the patient being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of "Living Well with Kidney Disease" in an effort to increase education about and awareness of the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labeling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care partners should feel supported to live well through concerted efforts by kidney care communities, including during pandemics. In the overall wellness program for patients with kidney disease, the need for prevention should be reiterated. Early detection with prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures across populations, professionals, and policy makers, applicable to both developed and developing countries.

Identifiants

pubmed: 33741269
pii: S1769-7255(21)00027-4
doi: 10.1016/j.nephro.2021.02.001
pii:
doi:

Types de publication

Editorial

Langues

fre

Sous-ensembles de citation

IM

Pagination

69-73

Investigateurs

Philip Kam Tao Li (PK)
Kamyar Kalantar-Zadeh (K)
Sharon Andreoli (S)
Alessandro Balducci (A)
Sophie Dupuis (S)
Latha Kumaraswami (L)
Vassilios Liakopoulos (V)
Siu-Fai Lui (SF)
Gamal Saadi (G)
Ifeoma Ulasi (I)

Informations de copyright

Copyright © 2021 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Kamyar Kalantar-Zadeh (K)

International Federation of Kidney Foundation-World Kidney Alliance (IFKF-WKA), Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine, Orange, California, USA. Electronic address: kkz@uci.edu.

Philip Kam-Tao Li (PK)

Department of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China. Electronic address: philipli@cuhk.edu.hk.

Ekamol Tantisattamo (E)

Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, California, USA.

Latha Kumaraswami (L)

Tanker Foundation, Chennai, India.

Vassilios Liakopoulos (V)

Division of Nephrology and Hypertension, First Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Siu-Fai Lui (SF)

Hong Kong Kidney Foundation and the International Federation of Kidney Foundations-World Kidney Alliance, Hong Kong, China.

Ifeoma Ulasi (I)

Renal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria.

Sharon Andreoli (S)

James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, USA.

Alessandro Balducci (A)

Italian Kidney Foundation, Rome, Italy.

Sophie Dupuis (S)

World Kidney Day Office, Brussels, Belgium.

Tess Harris (T)

Polycystic Kidney Disease Charity and Kidney Patients UK, London, UK.

Anne Hradsky (A)

World Kidney Day Office, Brussels, Belgium.

Richard Knight (R)

American Association of Kidney Patients, Tampa, Florida, USA.

Sajay Kumar (S)

Tanker Foundation, Chennai, India.

Maggie Ng (M)

Hong Kong Kidney Foundation, Hong Kong, China.

Alice Poidevin (A)

World Kidney Day Office, Brussels, Belgium.

Gamal Saadi (G)

Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt.

Allison Tong (A)

Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH